Study reports a novel broad-spectrum antiviral drug class with activity against SARS-CoV-2
Telehealth may be here to stay
2 December 2021Study finds new pollutants associated with an altered ratio of baby boys to girls
2 December 2021Study reports a novel broad-spectrum antiviral drug class with activity against SARS-CoV-2
The COVID-19 pandemic and resurgence of infections by other respiratory RNA viruses such as respiratory syncytial virus (RSV) in children has caused an urgent need for the development of orally available broad-spectrum antiviral therapeutics.
